The Physicochemical Principles Governing Nicotine Delivery from Oral Nicotine Pouches
Related Experiment Video
Updated: Oct 28, 2026

A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
1Department of Materials Science and Engineering, Division of Applied Materials Science, Ångström Laboratory, Uppsala University, Box 524, 75120 Uppsala, Sweden.
Abstract:
Nicotine pouches represent a rapidly expanding category of tobacco-free oral nicotine products. While these products are often compared primarily on the basis of nicotine content, evidence from in vitro dissolution/permeation studies and controlled clinical pharmacokinetic studies shows that nicotine delivery is governed by a complex interplay between physicochemical and formulation-related parameters. Moisture content, water activity, pH, nicotine speciation, matrix composition, particle morphology, and pouch architecture collectively influence nicotine dissolution, transport, and absorption through the oral mucosa. This review examines nicotine pouches from a pharmaceutical and drug-delivery perspective, treating them as engineered oral delivery systems rather than conventional consumer products. The mechanisms governing nicotine release are discussed in relation to acid-base chemistry, diffusion phenomena, hydration dynamics, and matrix design. Emphasis is also placed on the distinction between moist and dry pouch formulations and how these product families differ in hydration state, transport behavior, sensory properties, and release kinetics. The review further evaluates matrices, humectants, pH modifiers, nicotine sources, and emerging alternative carrier materials. Together, in vitro characterization and clinical PK data indicate that nicotine delivery depends on the coupled effects of water availability, matrix structure, nicotine release and local pH conditions. Understanding nicotine pouches as controlled oral delivery systems provides a framework for improved product characterization, more meaningful performance comparisons, and development of technologies with tailored pharmacokinetic profiles.
More Related Videos
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
08:47Spectral Confocal Imaging of Fluorescently tagged Nicotinic Receptors in Knock-in Mice with Chronic Nicotine Administration
Published on: February 10, 2012
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more effectively...
Drug Delivery: Enteral Route
Drugs in...
Oral Drug Delivery Systems: Introduction
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...